default author photo

Junhun Cho

Sungkyunkwan University - Samsung Medical Center

81, Irwon- Ro

Gangnam-gu

Seoul, 135-710

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

1

DOWNLOADS

46

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Phase II Brentuximab Vedotin Trial for Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas

Number of pages: 82 Posted: 21 Feb 2019
Sungkyunkwan University - Division of Hematology-Oncology, University of Ulsan - Department of Oncology, Yonsei University - Department of Internal Medicine, Korea Institute of Radiological and Medical Sciences, National Cancer Center, Korea, National Cancer Center, Korea, University of Ulsan - Department of Oncology, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Samsung Medical Center, University of Ulsan - Asan Medical Center, Yonsei University - College of Medicine, National Cancer Center, Korea, Korea Institute of Radiological and Medical Sciences, University of Ulsan - Department of Oncology and Sungkyunkwan University - Division of Hematology-Oncology
Downloads 46 (1,121,190)

Abstract:

Loading...

Brentuximab, non-Hodgkin lymphoma, CD30, Epstein-Barr virus, multiple myeloma oncogene-1